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Real time PCR is the mainstay of current nucleic acid assays, underpinning applications in
forensic science, point-of-care diagnostics and detection of bioterrorism agents. Despite its broad
utility, the search for new tests continues, inspired by second and third generation DNA
sequencing technologies and fuelled by progress in single molecule ﬂuorescence spectroscopy,
nanotechnology and microfabrication. These new methods promise the direct detection of nucleic
acids without the need for enzymatic ampliﬁcation. In this feature article, we provide a chemist’s
perspective on this multidisciplinary area, introducing the concepts of single molecule detection
then focussing on the selection of labels and probe chemistry suitable for generating a signal
detectable by ultrasensitive ﬂuorescence spectroscopy. Finally, we discuss the further developments
that are required to incorporate these detection platforms into integrated ‘sample-in-answer-out’
instruments, capable of detecting many target sequences in a matter of minutes.
Introduction
The impact of the polymerase chain reaction (PCR) on the
ﬁelds of molecular biology, DNA sequencing, mRNA
expression studies, genetic analysis, molecular diagnostics
and forensic science has been revolutionary. The ability to
amplify nucleic acid sequences of interest exponentially prior
to their analysis has been central to countless applications in
the last quarter of a century.1 At the same time, the advent of
analytical techniques with extremely low limits of detection
(down to single molecules) and lab-on-a-chip devices has led to
technologies that do not require ampliﬁcation of nucleic
acids.2 Progress has been most dramatic in the ﬁeld of DNA
sequencing, where the drive toward the $1000 genome has
accelerated the development of second and third generation
platforms that generate sequence data in a massively parallel
manner from a few or even individual DNA molecules.
Commercial platforms have been developed by Roche 454
Life Sciences, Illumina, Applied Biosystems, Helicos
Biosciences and Paciﬁc Biosciences among others. Some of
the core design principles that are central to the material
covered in this feature are nicely illustrated in a couple of
examples from this rapidly evolving ﬁeld.
In Illumina’s sequencing-by-synthesis method, clonal arrays
of B1000 copies of the molecule to be sequenced are
constructed on the surface of an optically transparent ﬂow
cell by polymerase ampliﬁcation.3 Sequence information is
then generated by extension of a primer using reversible dye
terminator chemistry with four ﬂuorescent dNTPs each
labelled with a diﬀerent colour (Fig. 1A). The 30-oxygen of
the ﬂuorescent dNTP is blocked from further extension by the
presence of an azidomethyl group. Unincorporated dNTPs are
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then washed out of the ﬂow cell and the identity of the
attached nucleotide established by imaging using total internal
reﬂection ﬂuorescence microscopy (TIRFM) before cleavage
of the ﬂuorophore and 30-protecting group. This is achieved
using a Staudinger reaction between a water soluble phosphine
and the azides, unmasking two hemiaminals which are rapidly
hydrolysed (Fig. 1B). The released 30-OH is then available for
reaction in another round of single base extension.
Paciﬁc Biosciences’ single molecule real time (SMRT)
sequencing method takes a more direct approach.4 Here, the
processive incorporation of nucleotides by an individual
polymerase is monitored (Fig. 2A). The ﬂuorescent label is
attached to the e-phosphorus atom of a modiﬁed 20-deoxy-
nucleotide pentaphosphate (dN5P) and is thus ejected with the
leaving group in the extension reaction (Fig. 2C). While this
takes place, the dye is held in close proximity to the polymerase
for a few hundred milliseconds, generating a ‘pulse’ of
colour speciﬁc to each base (Fig. 2B). The product is an
unmodiﬁed DNA strand which can continue to participate
in polymerisation. Since the KM of the DNA polymerase is in
the mM range, tremendous spatial resolution is required
to ensure that only triphosphates undergoing reaction
give rise to signal. This is achieved by the use of
nanofabricated zero-mode waveguide (ZMW) structures
which can illuminate an incredibly small volume of
10–20 zeptolitres (10–20  1021 L).5
The science underlying these innovations is truly multi-
disciplinary; chemically modiﬁed nucleotides/nucleic acids
for signal generation are combined with ﬂuidic technology
and sophisticated ﬂuorescence detection methods. However,
the detailed information generated by sequencing is unnecessary
for small scale SNP analysis or pathogen detection.
Fluorescence-based real time PCR has been the method
of choice for these applications in recent years, which we
reviewed ﬁve years ago.6 These assays typically rely on a
ﬂuorogenic oligonucleotide for recognition of a sequence of
interest in the amplicon. Real time PCR is now widely used for
nucleic acid-based diagnostics, and instruments for automated
preparation of assay-ready samples (e.g. QIAsymphony by
Qiagen), or for integrated sample processing, ampliﬁcation
and ﬂuorescence measurement (e.g. the GeneXpert by
Cepheid) have been marketed to meet the clinical need for
‘sample-in-answer-out’ capability. However, just as the Sanger
method has evolved into second and third generation
sequencing technologies, there has been a move towards
sequence analysis platforms that rely on ultrasensitive
Fig. 1 (A) Key steps in sequencing-by-synthesis using dye-labelled reversible terminators. (B) Chemical reactions occurring in the cleavage of dye
molecule and 30-blocking group.
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detection for the development of rapid assays that do not
require PCR ampliﬁcation of the target DNA.2
In this feature article, we discuss the progress that has
been made toward developing this next generation of
ﬂuorescence-based genetic analysis technologies. We outline
the principles of single molecule detection, discuss appropriate
labelling chemistry for these applications and illustrate
examples of assays that are being developed for use in this
context. We have concentrated solely on methods that
generate ﬂuorescence readout, although much progress has
been made in colourimetric, electrochemical and electronic
detection. The reader is directed to other reviews covering
these areas.7–9
Single molecule ﬂuorescence spectroscopy (SMFS)
SMFS has become an established biophysical technique since its
ﬁrst demonstration nearly 35 years ago.10 The measurement of
single ﬂuorophores is now a routine practice in many labora-
tories as a result of technological advances, particularly in the
20 years since the ﬁrst observation of single Rhodamine 6G
molecules dissolved in water at room temperature.11 Commercial
instruments, such as the MicroTime 200 by PicoQuant, have
become available, underlining the maturity of the technology.
The detailed technical development of SMFS and its application
to studying biological questions have been reviewed extensively
by leading practitioners in the ﬁeld.12–18 As a result, this section is
intended only to illustrate the basic principles underlying the
analytical applications described in this article.
In order for single molecule detection (SMD) to be
achieved, several conditions must be met. To maximise the
signal, the detector must be very sensitive—typically,
avalanche photodiodes (APDs), or charge-coupled device
(CCD) cameras are used, and emitted photons must be
collected very eﬃciently, usually by microscope objectives with
very high numerical aperture (NA). The minimisation of
background noise resulting from ﬂuorescent impurities or
Raman scattering from solvent molecules or bulk solutes is
also of critical importance. This goal can be achieved by
reducing the observation volume, since signals from bulk
species increase with the volume sampled, while those from
the single ﬂuorophore of interest do not. There are three
strategies for minimising the observation volume of particular
interest for analytical applications: confocal illumination, total
internal reﬂection microscopy (TIRFM) and the use of zero-
mode waveguides (ZMWs), each of which are described below.
Finally, if analytes are moving, either by Brownian motion or
in ﬂowing samples, it is necessary to collect data in a time-
gated fashion, so that signals from individual molecules
appear as discrete ‘bursts’ of ﬂuorescence.
In the confocal setup (Fig. 3A), excitation light from a laser
source is focussed by a microscope objective to a diﬀraction
limited spot with a diameter of r1 mm,19 whose radial
intensity proﬁle obeys a Gaussian function. Emitted photons
are collected by the same objective, separated from excitation
light by a dichroic mirror, and a pinhole (typically 50 mm in
width) is positioned in the conjugate image plane to reject out-
of-focus light. This arrangement of optical components deﬁnes
an elliptical observation volume of B0.5 fL (Fig. 3B). Even
when sampling this minute volume, it is necessary to work at
low concentrations of analytes to ensure observation of one
molecule at a time. A simple calculation tells us that a
concentration of 3.3 nM would lead to an average of one
molecule occupying this detection volume at a given time, and
to ensure that discrete bursts from single molecules are
observed, it is necessary to work at analyte concentrations of
10–100 pM.20 In this single molecule regime, it is possible to
obtain multiple parameters such as ﬂuorescence intensities,
lifetimes, anisotropy and Fo¨rster resonance energy transfer
(FRET) eﬃciency,21 though intensity and FRET are perhaps
the most useful for molecular diagnostics.
In contrast to discrete burst analysis, ﬂuorescence correla-
tion spectroscopy (FCS) relies on measuring the temporal
Fig. 2 Single molecule real time sequencing. (A) Extension of a
primer by a single polymerase immobilised within a zero-mode
waveguide (ZMW). (B) Fluorescence trace observed during extension.
(C) Chemical mechanism of polymerisation reaction using ﬂuores-
cently-labelled 20-deoxynucleotide pentaphosphate (dN5P).
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ﬂuctuations in intensity, where the detection volume can be
occupied by multiple ﬂuorophores. It is most useful in analysis
of more concentrated samples in the 1–100 nM range.16,22
Since these ﬂuctuations are due to molecules diﬀusing in and
out of the detection volume, the autocorrelation function,
G(t), that is generated enables measurement of diﬀusion
coeﬃcients and molecular dynamics, for example in ss- and
dsDNA.23 FCS is most eﬀective at distinguishing species with
very large diﬀerences in molecular weight (and therefore
hydrodynamic radius), which limits its usefulness in molecular
diagnostics. For this reason, ﬂuorescence cross correlation
spectroscopy (FCCS), ﬁrst proposed in 1994,24 was developed
and ﬁrst realised in 1997.25 In this technique, two lasers are
focussed into the same confocal volume, and the ﬂuctuation in
ﬂuorescence from two separately excited dyes can be com-
pared, which indicates whether they are co-localised (Fig. 3C).
FCCS has been used to monitor PCR in which the forward
and reverse primers are labelled with diﬀerent dyes that there-
fore become associated in the amplicon.26 The related two
colour coincidence detection (TCCD) experiment extends the
sensitivity to fM concentrations.27 It is perhaps worth
emphasising for readers who are unfamiliar with SMFS that
bulk measurements cannot reveal association in these systems
since there is no change in the ﬂuorescence intensity of either
Fig. 3 Conﬁgurations for SMFS. (A) Confocal microscope setup. (B) Detection of single molecules diﬀusing through a confocal illumination
volume (B1 mm diameter,B0.5 fL). Molecules that are labelled with a ﬂuorophore that can be excited by the laser wavelength can give rise to a
ﬂuorescence burst in one colour (molecule a), or two colours (molecule b) if undergoing Fo¨rster resonance energy transfer (FRET). If the path of
the molecule does not take it through the illuminated volume, no emission occurs (molecules c and d). (C) Detection using two overlapped laser
beams. Dual-labelled species that encounter the overlapped region during Brownian motion exhibit ﬂuorescence from both reporters (molecule e),
while some molecules are only excited by one laser due to imperfect overlap (molecule f). (D) Objective-based TIRFM setup. (E) Detection of
ﬂuorescence by TIRFM on a microscope slide. Due to the evanescently-decaying illumination ﬁeld (depthE 100 nm), only surface-bound species
(molecule g) are excited for long enough to generate a signiﬁcant signal above background, whereas mobile species (molecule h) encounter the
illuminated volume only brieﬂy due to Brownian motion and therefore do not build up a signiﬁcant signal above noise in any given pixel when
averaged over the duration of the measurement. (F) Detection of a single molecule inside a nanofabricated ZMW (diameter 20–100 nm), with an
illuminated volume of 10–20 zL.
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reporter; it is only with the spatial and temporal resolution
oﬀered by SMD that such information can be obtained.
As well as confocal optics, two other illumination methods
important in bioanalytical devices are TIRFM and ZMWs,
both of which rely on evanescent waves to generate a very
small illumination volume. In TIRFM, excitation light is
directed either by a prism or a microscope objective
(as in Fig. 3D) to a slide or coverslip at an angle greater than
the critical angle, so that total internal reﬂection occurs. As a
result, the excitation beam does not propagate into the sample,
but an exponentially decaying evanescent wave at the interface
penetrates the sample generating a thin ﬁlm of illumination
(B100 nm) where its intensity is suﬃcient to excite ﬂuoro-
phores (Fig. 3E).28,29 ZMWs are nanofabricated cylindrical
holes in a metal ﬁlm, whose diameter (20–100 nm) is much
smaller than the wavelength of the excitation light (Fig. 3F).
Under these conditions there are no propagating modes, and
an exponentially-decaying evanescent ﬁeld produces an
illuminated volume of B20 zL. In contrast to confocal optics
then, an average of one molecule in the detection volume is
produced by an analyte concentration of 83 mM and single
molecule detection of coumarin-labelled dCTP at 10 mM can
be achieved.30
SMFS in microﬂuidic devices
The ability to detect single molecules opens up the possibility
of directly detecting nucleic acids without the need for
enzymatic ampliﬁcation. Quantifying DNA without using
PCR, or RNA without RT-PCR, could oﬀer several
advantages. Firstly, the ampliﬁcation process can produce
artifacts,31,32 which would be negated by direct detection. This
problem is particularly important in multiplex PCR, where the
increased probability of primer–dimer formation or mispriming
generally limits the number of simultaneous reactions to
10–20.33–35 Additionally, when biological samples are used,
the presence of PCR inhibitors in the matrix such as urea from
urine,36 melanin from skin,37 and immunoglobulin G (IgG),38
haemoglobin or lactoferrin39 from blood can obfuscate the
results. Though these contaminants can be removed by sample
pre-processing,40 this would add another layer of complexity
to integrated analysis instruments. Finally, ‘while-you-wait’
point-of-care applications or detection of bioterrorism agents
place exacting demands on the total assay time. Even though
rapid cycle real time PCR reactions are routinely completed
in o30 minutes,41 and reaction times in continuous ﬂow
microﬂuidic devices can be shortened to 10–20 minutes while
maintaining acceptable yields of the product,42,43 eliminating
this step altogether would be advantageous in these contexts.
Cepheid’s GeneXpert system, which integrates sample
preparation and real time PCR, can produce results inB1 hour,
while ultrasensitive platforms requiring less rigorously puriﬁed
nucleic acid and a single hybridisation reaction rather than
multiple thermal cycles may be able to provide data much
more rapidly.
However, having a detection limit of one molecule does not
guarantee access to an ultrasensitive molecular diagnostics
technology, particularly one with high throughput. Any
analytical test must provide a statistically signiﬁcant level of
conﬁdence in the readout, which may be the presence or
absence of a sequence, or its concentration. In SMFS
techniques, this depends upon observing a greater number of
events in the presence of nucleic acid than in its absence. Due
to the small illuminated volumes necessary for SMD, low
concentrations of analytes require extended acquisition times
before this condition is satisﬁed. In confocal measurements in
open volumes, for example, this is caused by the low diﬀusion-
limited encounter rate of dilute ﬂuorescent species with the
femtolitre-sized detection volume. The time required to detect
a sample of a given concentration with a set conﬁdence
interval can be calculated using Poisson statistics and the
measured event rates in the presence and absence of
the analyte. Li et al. estimated the time required to detect
the presence or absence of dual-labelled DNA by TCCD at
1 pM and 100 fM with 99% conﬁdence to be 2 and 60 minutes
respectively.27 How does this compare with the throughput of
PCR? Let us consider human genomic DNA sampled using a
buccal swab. The expected yield from this procedure is
approximately 1 mg.44 Even if the nucleic acid is concentrated
to 5 mL, this still represents a concentration of only approxi-
mately 100 fM, requiring an analysis time of B1 hour:
approximately twice the length of time required to carry out
a real time PCR assay. It is likely then, that to compete with
PCR in throughput, it is necessary to devise ways to enhance
the rate of data acquisition possible in SMD.
The problem of rapid detection of rare analytes is one of the
major drivers for the development of systems which employ
SMD in microﬂuidics, since ﬂowing the ﬂuorescent molecules
through the detection volume either by pressure-driven or
electrically-driven means could greatly enhance the encounter
rate and hence reduce the analysis time dramatically. In
addition to this advantage, the use of microﬂuidics in ultra-
sensitive diagnostic devices oﬀers other potential beneﬁts,
such as eﬃcient handling of small sample volumes and the
possibility of cheap mass production.45,46 The paradigm of
combined microﬂuidics and SMD was described in one review
as ‘‘the holy grail of mTAS’’ (micro total analysis systems),47
and has received considerable interest in the last 5–10 years.48
In fact, microﬂuidics were used in the early development of
ultrasensitive ﬂuorescence detection, where the ﬂow cell of a
ﬂuorescence activated cell sorter (FACS) was interfaced with
confocal detection optics (Fig. 4A), ﬁrst in the detection of
several thousand Rhodamine 6G chromophores,49,50 then
single molecules of phycoerythrin,51 and ﬁnally single
Rhodamine 6G molecules.11 In these examples, hydrodynamic
focussing led to a sample stream diameter ofB10 mm, which is
larger than the excitation beam waist. As a result, not all of the
molecules ﬂowed through the device could be detected. Since
then, various schemes to increase the proportion of molecules
detected by forcing more of the analyte through the detection
volume have been pursued. Improved hydrodynamic
focussing,52 narrow capillaries,52,53 electrokinetic forces
(Fig. 4B),54 oil-in-water microdroplet streams (Fig. 4C),55,56
and nanofabricated channels (Fig. 4D)57–59 have all been used
to conﬁne the sample and thus enhance the detection
eﬃciency. An alternative approach uses cylindrical optics to
expand the detection volume in a single dimension, generating
a sheet-like illumination volume which can increase the
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detection eﬃciency to B100% in larger microchannels with a
width of 100 mm.60 Using a combination of hydrodynamic and
electrokinetic focussing, Wang and co-workers estimated that
the acquisition time required to detect 70 pM of unlabelled
single stranded DNA hybridised to a complementary molecular
beacon with 99% conﬁdence dropped from B200 s to o4 s
due to the greater encounter rate achieved.54
In devices such as these, the throughput is eﬀectively limited
by the ﬂuorescence lifetime (in the nanosecond range for
organic dyes) because the residence time of a ﬂuorophore in
the detection volume is inversely proportional to its velocity,61
meaning that fewer photons can be emitted per molecule as the
ﬂow rate is increased. For example, Foquet et al. were able to
achieve SMD in submicrometre-sized ﬂuidic channels using
electrokinetic ﬂow speeds up to 10 cm s1 but noted the
requirement for precise alignment of the laser focus with the
channel and a marked decrease in the number of detected
photons due to the decreased illumination time (10 ms).58
Okagbare and Soper have proposed an alternative method
for achieving high throughput SMD, using wideﬁeld
illumination to image thirty microﬂuidic channels simulta-
neously (Fig. 4E).62 Modest ﬂow rates (B0.01 cm s1) were
used, but the highly parallel nature of the measurement could
allow detection of up to B7.65  106 molecules s1 using
narrower channels. The use of microﬂuidics also enables
sample manipulations that can improve detection eﬃciency,
such as deoxygenation for enhanced single pair FRET
(spFRET) measurements,63 recirculation of the sample
through a nL chamber allowing each molecule to be counted
multiple times,64 and concentration of target nucleic acid prior
Fig. 4 Microﬂuidic devices for SMD in ﬂow. (A) Modiﬁed FACS ﬂow cell using hydrodynamic focussing. (B) Device for combined
hydrodynamic/electrokinetic focussing of nucleic acid molecules. (C) Device for SMFS in oil-in-water microdroplets, with retractable channel
constriction for conﬁnement of droplets causing increased illumination time required for SMD. Reproduced from ref. 56. (D) Nanofabricated
channels narrowing from a width of 10 mm to 500 nm for a length of 10 mm. Reproduced from ref. 59. (E) Analysis chip with multiple
microchannels (30 mm width) for high throughput parallel SMD. Reproduced from ref. 62.
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to hybridisation by micro-evaporation. The combination of
the last two processes allowed detection of ssDNA at initial
concentrations as low as 50 aM in an acquisition time of 100 s
after concentration.65 It should be noted that the evaporation
step reported required a prohibitive 20 h, though it may be
possible to reduce this signiﬁcantly by modiﬁcation of the
operating parameters.
Selection of ﬂuorescent labels for SMFS
Researchers who practise SMFS tend to work from a smaller
palette of ﬂuorophores than those carrying out ensemble
measurements, who have a wide variety of labels at their
disposal.66 This is largely because the short occupation time
of ﬂuorophores in the illuminated volume and the high
illumination intensities used in SMD place exacting demands
on the photophysical properties of the dye. The number of
photons emitted by a reporter is ultimately limited by the
number of excitation/emission cycles it can complete while in
the detection volume, which in turn depends on its transit time
across the detection volume and its characteristic ﬂuorescent
lifetime, since the molecule must return to its ground state
before another excitation photon can be absorbed. High
illumination intensities (>108 kW cm2) are used in SMD
to ensure that the ﬂuorophore is excited rapidly after relaxa-
tion. When analytes are undergoing Brownian motion, the
duration as well as the rate of their encounters with a
femtolitre detection volume are determined by their diﬀusion
coeﬃcients. A mean transit time of around 100 ms is typical for
short DNA duplexes.67 Given a ﬂuorescence lifetime of 4 ns, a
maximum of 25 000 photons could be emitted in this time.
These propagate in all directions, although high NA objectives
can collect a relatively high fraction of emitted photons
(e.g. 26% of photons for NA = 1.3), it has been reported
that once ineﬃciencies in the detector and other components
are taken into account, an overall eﬃciency as low asB1% is
achieved,68 i.e. 250 photons. When molecules are driven
through the probe volume by ﬂow, the occupation time may
be even shorter, hence even fewer photons may be emitted.
These numbers are further limited by quantum eﬃciency and
bleaching eﬀects or transitions into dark states. To obtain the
maximum signal from a label, it is therefore important that the
reporter displays a large extinction coeﬃcient, high quantum
yield, good photostability at high laser power and a short
excited state lifetime. These considerations mean that
ﬂuorophores selected for SMFS studies must meet stringent
selection criteria.
Since laser induced ﬂuorescence (LIF) is the most suitable
excitation mode for SMD, the dyes that have been most widely
used are those eﬃciently excited by most common lasers;
among these are the argon ion (488 nm), frequency doubled
Nd:YAG (532 nm), krypton ion (568 nm) and HeNe (633 nm)
laser sources. Initially, the familiar historic dyestuﬀs
(ﬂuoresceins, rhodamines and cyanines) were used, though
these have largely been superseded by superior synthetically
modiﬁed versions, available from many suppliers (Invitrogen,
ATTO TEC, GE Healthcare, Glen Research, Lumiprobe and
Dyomics among others), each of which oﬀer distinct patented
ﬂuorophore structures (Fig. 5, Table 1). Reactive derivatives
available for labelling of oligonucleotides include phosphor-
amidites for incorporation during automated synthesis,
carboxylic acids and active esters for reaction with amino-
modiﬁed oligonucleotides, maleimides and iodoacetamides for
labelling thiolated nucleic acids, and amines for coupling to
carboxylic acids and electrophiles. In addition to these
reagents, azide- and alkyne-functionalised ﬂuorophores are
becoming increasingly available to take advantage of the
eﬃcient conjugation possible via Cu (I)-catalysed click
chemistry, which is becoming a well-established methodology
for synthetic manipulations of nucleic acids.69 In general,
labelling by phosphoramidite chemistry is the most preferable
due to the high coupling yields obtained. However, most
chromophores suitable for SMFS (particularly rhodamines
and cyanines) are unstable to oligonucleotide deprotection in
concentrated aqueous ammonia or other basic media, in which
case post-synthetic modiﬁcation is necessary.
In the ﬁrst demonstration of SMD, 80–100 ﬂuorescein
molecules were conjugated to a single g-globulin molecule
via a polyethyleneimine linker and detected following excita-
tion by an Ar ion laser.10 Despite its widespread use in many
applications, ﬂuorescein is not now widely used in SMFS due
to its susceptibility to photobleaching (of most importance in
imaging applications) and the pH-dependence of its quantum
yield, which is due to ionisation of the phenolic group
(pKa 6.4). In order to improve ﬂuorescence at neutral pH,
the 2,7-diﬂuoro derivative of ﬂuorescein, Oregon Green, was
synthesised. The electron withdrawing eﬀect of the ﬂuorine
atoms reduces the pKa to 4.8, making this dye suitable for
detection at or below pH 7.70
Dyes from the rhodamine family are perhaps the most
commonly studied by SMFS, and many derivatives are
available. The ﬁrst detection of single ﬂuorophores in aqueous
conditions twenty years ago was of a 100 fM solution of
Rhodamine 6G excited at 532 nm,11 and sulfonated/
elaborated derivatives of that dye, Alexa Fluor 532 and ATTO
532, remain popular in the present day.71 For excitation at
488 nm, Rhodamine Green (Rhodamine 110) or its sulfonated
derivatives Alexa Fluor 488 or ATTO 488 are commonly used;
these labels are preferred to ﬂuorescein derivatives, because
they are completely insensitive to pH in the useful analytical
range, 4–8. Due to the instability of the rhodamine chromo-
phore, its incorporation during oligonucleotide synthesis
has to be carried out carefully, using 0.05 M K2CO3 or
tert-butylamine/methanol/water (1 : 1 : 2) for deprotection.72
The introduction of sulfonate groups is a common strategy
for improving the performance of ﬂuorophores.73,74 The
reduced hydrophobicity results in increased water solubility
and a lower tendency to form aggregates in water. While
aggregate formation is not a major concern at the low
concentrations typically used for SMFS, dye molecules may
interact with each other intramolecularly if bioconjugates are
multiply-labelled, or otherwise with hydrophobic amino acid
side chains or nucleobases, adversely aﬀecting ﬂuorescence
properties.75–77 High water solubility is particularly important
for eﬃcient post-synthetic labelling of deprotected oligo-
nucleotides, though not for incorporation in oligonucleotide
synthesis, where acetonitrile is the solvent of choice. For this
reason the sulfonate groups of Cy3, Cy5 and Cy5.5 are absent
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Fig. 5 Chemical structures of ﬂuorophores commonly used in SMFS. For phosphoramidite derivatives of Cy3, Cy5 and Cy5.5, R = H; for other
reactive derivatives, R = SO3
.
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in their phosphoramidite derivatives. In contrast, Alexa Fluor
647, a cyanine dye related to Cy5, bears four sulfonate
groups,78 and is particularly resistant to self-quenching in
protein conjugates with a high degree of labelling.79
While cyanine dyes are widely used for labelling of nucleic
acids, they display photoswitching behaviour with a complex
mechanism involving sticking/unsticking to DNA, transition
to triplet states and cis/trans isomerisation. A number of these
states are non-ﬂuorescent, leading to blinking and the
generation of a large ‘zero peak’ in spFRET measurements.78
This property is displayed by Cy3, Cy5 and the tetrasulfonated
Alexa Fluor 647. While blinking phenomena can be exploited
for imaging beyond the diﬀraction limit,80,81 these processes
are generally undesirable for the analytical applications
discussed here because they reduce the detection eﬃciency.
To eliminate eﬀects due to photoisomerisation, Cy3B, a
conformationally locked analogue of Cy3, has been
developed.82 This modiﬁcation has a dramatic eﬀect on the
quantum yield, which increases from 0.04 for Cy3 to 0.7 for
Cy3B. This ﬂuorophore has been shown to be an eﬃcient donor
in spFRET experiments.83 For detection in the far red part of
the spectrum the carbopyronine dye, ATTO 647N,84 is a
conformationally rigid alternative to Cy5 and Alexa Fluor 647.
Fluorescent intercalators are alternative labels for SMD of
DNA, obviating the need for chemical derivatisation of
oligonucleotides. Dimeric cyanine dyes, such as YOYO-1
and TOTO-1, are usually preferred for SMFS due to their
high aﬃnity for dsDNA, large ﬂuorescence enhancements
upon binding and the availability of many derivatives whose
absorption spectra enable eﬃcient excitation by widely used
laser sources.85 However, their use in SMFS is usually limited
to the staining of single polynucleotides with many bound
intercalators,61,86–89 rather than the speciﬁc detection of short
sequences of most interest in genetic analysis.
Quantum dots, luminescent core–shell semiconductor
nanocrystals of diameter 2–10 nm, have been the subject of
much interest since the ﬁrst descriptions of their use in
biological imaging in the late 1990s.90,91 The most popular
core materials in analytical applications are CdSe and CdTe,
among the ﬁrst to be synthesised. Commercial suppliers
(e.g. Quantum Dot Corporation, now owned by Invitrogen,
Evident Technologies and Crystalplex) can provide capped
core–shell nanoparticles, and particles functionalised with
groups such as streptavidin, amines and carboxylic acids,
enabling conjugation to oligonucleotides. Their popularity in
SMFS stems largely from their enhanced brightness, broad
excitation spectra and resistance to photobleaching, but inter-
mittent emission at the single molecule level caused by photo-
blinking can cause problems.92 Careful optimisation of surface
chemistry to ensure stability and solubility in aqueous media is
also required. Reviews comparing quantum dots with organic
dyes,93 as well as describing their use in biomolecular assays
and single molecule detection have recently been published,94–96
so we do not replicate this material here.
Assays for ultrasensitive detection of nucleic acids
With suitable instrumentation and labels available, the
remaining requirement for ultrasensitive nucleic acid detection
is an assay that generates a detectable signal in the presence of
a speciﬁc sequence. Strategies used for real time PCR that rely
on enzymatic modiﬁcation of a probe by the polymerase for
signal generation, either by hydrolytic cleavage, as in
TaqMan,101 or extension of a primer element, as in
Scorpions,102 or Ampliﬂuor primers,103 are undesirable for
ampliﬁcation-free genetic analysis methods. Recently, assays
that use rolling circle ampliﬁcation combined with nicking
endonuclease signal ampliﬁcation (RCA-NESA),104 or
Table 1 Fluorescence properties of organic ﬂuorophores commonly used in SMFS. Parameters are reported for the free dyes and may be
signiﬁcantly altered upon conjugation to nucleic acids
Dye lex/nm lem/nm e/M
1 cm F t/ns Available reactive derivatives
FluoresceinR,97 490 514 75 000 0.92 4.1 –NCS, –CO2H, NHS ester, –NH2, –N3, maleimide, phosphoramidite
Oregon GreenS,I 490 514 82 400 0.97 4.1 –CO2H, NHS ester, –NH2, maleimide, –N3, –alkyne, –iodoacetamide
Alexa Fluor 488S,I 495 519 73 000 0.92 4.1 –CO2H, NHS ester, –NH2, maleimide, –N3, –alkyne, –iodoacetamide
ATTO 488S,A 501 523 90 000 0.80 3.2 –CO2H, NHS ester, –NH2, maleimide, –N3, –iodoacetamide
Rhodamine Green
(Rhodamine 110)
504S,I 532S,I 73 000S,I 0.92R,98 4.2R,99 –CO2H, NHS ester
Rhodamine 6G 524S,I 552S,I 92 000S,I 0.95R,98 4.08R,100 –CO2H, NHS ester
Alexa Fluor 532S,I 531 554 81 000 0.61 2.5 NHS ester, maleimide
ATTO 532S,A 532 553 115 000 0.90 3.8 –CO2H, NHS ester, –NH2, maleimide, –N3, –iodoacetamide
TAMRAR,97 547 574 77 000 0.35 2.2 –NCS, –CO2H, NHS ester, –NH2, –N3, alkyne,
maleimide, phosphoramidite
Cy3R,82 548 562 150 000 0.04 o0.3 –CO2H, NHS ester, –NH2, maleimide, –N3,
–iodoacetamide phosphoramidite
Cy3BR,82 558 572 130 000 0.70 2.8 –CO2H, NHS ester, maleimide
Cy5S,G 646 664 250 000 0.27 1.0 –CO2H, NHS ester, –NH2, maleimide, –N3,
–iodoacetamide phosphoramidite
Alexa Fluor 647S,G 650 668 270 000 0.33 1.0 –CO2H, NHS ester, –NH2, maleimide, –N3,
–alkyne, –iodoacetamide
ATTO 647NS,A 644 669 150 000 0.65 3.4 –CO2H, NHS ester, –NH2, maleimide, –N3,
–iodoacetamide
Cy5.5S,G 673 692 190 000 0.23 1.0 –CO2H, NHS ester, –NH2, maleimide, –N3,
–iodoacetamide phosphoramidite
S—spectroscopic data provided by the supplier (I = Invitrogen, A = ATTO-TEC, G = GE Healthcare). R—spectroscopic data taken from the
literature (n = reference number).
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exonuclease III,105 to cleave ﬂuorogenic oligonucleotide
probes have been proposed as ultrasensitive methods for
DNA detection. The turnover of Molecular Beacons in the
cleavage reactions means that multiple ﬂuorescence signals can
be generated by a single unlabelled target molecule. This
process greatly increases the signal, leading to extremely low
limits of detection (85 fM and 20 aM respectively) without the
need for target ampliﬁcation by polymerase enzymes. As a
result, the risk of copying errors is removed, and less sophis-
ticated equipment is required because the assays proceed
under isothermal conditions and generate a signal detectable
by bulk ﬂuorescence spectroscopy. However, the linear nature
of the signal ampliﬁcation steps means that incubation times
are unavoidably longer than the corresponding exponential
process in PCR: 5 h for RCA-NESA and 20 h for the
exonuclease III assay at 4 1C. In the sections below, we have
concentrated on methods that have the potential to provide
sequence information on unlabelled nucleic acids of biological
origin in short timescales. These are divided into three
sections, based on the type of readout observed in the
measurement.
Intensity-based detection
Detection based on an increase in ﬂuorescence intensity in the
presence of the target nucleic acid is perhaps the simplest
approach conceptually. In the single molecule regime, this
typically involves deﬁning a threshold, then counting the
number of events (either bursts of ﬂuorescence or pixels, if
imaging is used) whose intensity exceeds this level (Fig. 6A).
As with real time PCR methods, staining with a ﬂuorescent
intercalator such as YOYO-1 can reveal the presence of double
stranded DNA.56 This signal could be used to conﬁrm sample
quality, or for sizing of circulating nucleic acids (CNA) stained
with TOTO-3 by analysis of burst sizes in ﬂow,106 but cannot
provide any sequence information.
Oligonucleotide probes that exhibit increased ﬂuorescence
upon hybridisation to their complementary sequence can
provide sequence-speciﬁc information. Molecular Beacons,
hairpin-structured oligonucleotides labelled with a ﬂuoro-
phore and quencher ﬁrst described by Tyagi and Kramer for
monitoring real time PCR reactions are one such probe
type.107 When hybridised, a ﬂuorophore and quencher at
either end of the stem sequence become distal, causing the
quantum yield of the reporter to increase signiﬁcantly
(Fig. 6B). As this mechanism of signal generation is not
dependent on any enzymatic modiﬁcation of the probe or
target nucleic acid, it is therefore potentially compatible with
ampliﬁcation-free detection, resulting in signiﬁcant interest in
the use of Molecular Beacons in ultrasensitive methods. Zhang
et al. used two Molecular Beacons, labelled with either Oregon
Green/Iowa Black or Cy5/BHQ-3 for detection and discrimi-
nation of synthetic single stranded targets at concentrations
down to 70 pM by counting bursts above a suitable threshold
from samples mounted on a microscope slide.108 The diﬀusion-
limited encounter rate from static measurements using
Molecular Beacons has been improved upon by the same
group using pressure-driven or electrokinetic ﬂow, improving
the data acquisition rate as discussed previously.54,56
However, the use of intensity alone as a means to identify
binding events has some inherent drawbacks. Given a high
eﬃciency and throughput of detection, the sensitivity becomes
limited by the background signal, i.e. the number of events
above threshold in the absence of the target. For Molecular
Beacon measurements, some of these result from imperfec-
tions in synthesis, such as the presence of hairpins that have
not been labelled with a quencher, or contamination with
residual free dye. Since most dyes compatible with SMFS are
unstable to standard oligonucleotide deprotection conditions,
the labelling reaction is typically carried out post-synthetically,
with the deprotected oligonucleotide in solution. As a result, it
is often diﬃcult to completely remove the excess free dye
used in the coupling reaction, even by HPLC. In addition,
thermodynamic equilibrium necessitates a small fraction of
open or ‘melted’ hairpins, even at temperatures below the Tm,
depending on the stem and loop sequences.67,109 While these
can usually be neglected, their number will eventually become
comparable to hybridised beacons as the concentration of the
target becomes extremely small relative to the concentration of
probes. Finally, the presence of autoﬂuorescent impurities
from the sample may also produce bursts above threshold.
Alternative designs that do not use an extrinsic ﬂuorophore–
quencher pair therefore have advantages if the synthesis of the
probes is simpliﬁed, as do detection methods using other
parameters in addition to intensity. Smart probes for example,
which rely on quenching of the ﬂuorophore by an oligo-dG
stem sequence, only require the incorporation of a single dye
molecule (Fig. 6C). Quenching occurs via photoinduced
electron transfer (PET) between the reporter (ATTO 655 or
the oxazine dyes MR121 and JA242) and the stem, due to the
low oxidation potential of guanine.110 In static confocal
measurements, smart probe binding to target nucleic acids
is monitored using three ﬂuorescence parameters: intensity,
ﬂuorescence lifetime and residence time.111 Reduction in
quenching by separation of the reporter and oligo-dG stem
leads to increased intensity and excited state lifetime, while
hybridisation to the target nucleic acid decreases the diﬀusion
coeﬃcient and hence prolongs the transit time through the
excitation volume. The average residence time is increased
fromB100 ms for an unhybridised smart probe to 180 ms when
hybridised to a 20 nt synthetic DNA target, and to 380 ms
when bound to a 157 nt PCR product.112 Using these
properties as three AND criteria reduces the background event
rate signiﬁcantly, thereby enhancing sensitivity to a synthetic
target from 1 nM using intensity alone, to 1 pM with multi-
parameter analysis. However, the residence time parameter
could not be used in devices using SMD in fast ﬂow, since
diﬀusion becomes negligible under these conditions.61 When
immobilised on a solid surface, functional smart probes could
be distinguished from those adsorbed by surface–dye inter-
actions by polarisation modulated excitation. This approach
enabled detection of synthetic ssDNA at 0.1 pM.113
Another synthetically simpliﬁed Molecular Beacon has been
described by Conley et al., where quenching in the closed
conformation is caused by formation of an H-dimer between
two dicyanomethylenedihydrofuran (DCDHF) ﬂuorophores.114
Blunt-ended hairpins modiﬁed with amino groups at the 30
and 50 termini are doubly-labelled using a DCDHF NHS-ester
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f S
ou
th
am
pt
on
 o
n 
04
 A
pr
il 
20
11
Pu
bl
ish
ed
 o
n 
31
 Ja
nu
ar
y 
20
11
 o
n 
ht
tp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
CC
042
15C
View Online
This journal is c The Royal Society of Chemistry 2011 Chem. Commun., 2011, 47, 3717–3735 3727
to form self-quenched intramolecular dimer (SQuID) Molecular
Beacons, while two separately labelled oligonucleotides are used
to form an immobilised intermolecular Molecular Beacon
for single molecule imaging studies by TIRFM (Fig. 6D). When
these beacons are opened by the target sequence, both chromo-
phores exhibit increased ﬂuorescence due to disruption of the
H-dimer. In the imaging detection mode, both reporters are
observed within a single pixel, resulting in a two-step photo-
bleaching signature that could be used to distinguish open
beacons from spurious ﬂuorescence. While the time required
for photobleaching is relatively long (5–10 s per ﬂuorophore
pair), the bleaching of many immobilised beacons could be
monitored simultaneously using wideﬁeld imaging, thereby
increasing the detection throughput.
Another approach, reported by Castro et al., is to concen-
trate ﬂuorescence from the solution onto the probe–target
duplex, so that binding events are observed as highly emissive
species above a constant background.115 This was achieved by
incorporation of a dUTP derivative labelled with a TAMRA/
BODIPY FRET pair during polymerase extension of a single
primer hybridised to a 1568 nt polynucleotide fragment
resulting from restriction digestion of pUC19 plasmid DNA
(Fig. 7A). The resulting 1468 bp duplex containedB50 labels,
enabling a 1.2 pM concentration of plasmid to be discrimi-
nated from the background due to unincorporated dUTP at a
concentration of 10 nM using burst counting in ﬂow following
a 200-fold dilution. This method has some potential draw-
backs. The use of enzymatic labelling requires removal of any
PCR inhibitors and introduces a potentially time consuming
step; the duration of the extension reaction described was 1 h,
though it may be possible to reduce this. More fundamentally,
the number of labels incorporated must be suﬃcient to out-
weigh the background, requiring relatively long products. One
advantage that results from this is that spurious products due
to primer–dimer formation should not produce suﬃciently
bright events to generate false-positives. Furthermore, reduc-
tion of the illuminated volume by confocal optics or the use of
narrow nanofabricated channels would reduce the back-
ground and perhaps extend the sensitivity to shorter products.
A method described by Dubus et al. uses aromatic polymers
to generate a large ﬂuorescent signal upon hybridisation of
capture oligonucleotides bound to magnetic microparticles
(Fig. 7B).116 The cationic polythiophene binds both single-
and double-stranded DNA, but undergoes a conformational
change upon binding the latter, becoming strongly ﬂuorescent
(Fig. 7C).117 The capture beads were conﬁned in a micro-
fabricated electromagnetic trap for imaging, allowing
detection of 11 aM synthetic ssDNA.
Co-localisation based detection
As outlined in Fig. 3C, one popular implementation of SMFS
involves using ﬂuorophores attached to separate interacting
biomolecules, leading to co-localisation of the dye molecules
upon binding. When the chromophores are then simulta-
neously excited in the observation volume resulting from
two overlapped laser beams, co-localisation gives rise to a
simultaneous burst of emitted photons from both dyes, some-
times called a coincidence event (Fig. 8A). This approach has
Fig. 6 (A) Intensity-based detection of nucleic acid targets. A
greater number of ﬂuorescence bursts above threshold are
observed upon hybridisation. (B) Mode of action of Molecular
Beacons (B), smart probes (C) and intermolecular quenched H-dimer
probes (D).
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advantages over the use of intensity alone for detection of
nucleic acids, because background coincidence events are not
caused by unconjugated dye molecules, unless there is a
signiﬁcant crosstalk between the two dyes (caused by ‘leaking’
of emission between detection channels), or if two dye mole-
cules enter the excitation volume simultaneously, either by
chance or non-speciﬁc association. Similarly, autoﬂuorescent
impurities are less likely to be detected in both channels.
The most convenient way of harnessing this technique for
detection of non-ﬂuorescent endogenous nucleic acids involves
the use of two ﬂuorescent probes which co-localise upon
hybridisation to the same unlabelled target molecule,
analogous to the ‘sandwich’ method used in immunoassays
(Fig. 8B). This approach was ﬁrst presented by Castro and
Williams for ampliﬁcation-free detection of genomic DNA,
where phage l genomic DNA was detected using two 15mer
peptide nucleic acid (PNA) probes, labelled with Rhodamine
Green and BODIPY-TR,118 and later for detection of genomic
DNA from Bacillus anthracis, the causative agent of
anthrax.119 A similar assay has been used to probe gene
expression using FCCS, where two labelled oligodeoxynucleo-
tide probes were hybridised either to cDNA produced by
reverse transcription,120 or directly to the mRNA.121
One disadvantage with homogenous ‘sandwich’-hybridisation
methods in the detection of unampliﬁed genomic DNA arises
because excess unhybridised ﬂuorescent probes are not
removed before analysis. As a result, the total concentration
of ﬂuorescent molecules must not exceed the single molecule
regime (r250 pM), because the probability of chance
coincidence events rises.122,123 However, it would be desirable
for high concentrations of ﬂuorescent probes to be used in the
rapid detection of unampliﬁed nucleic acids to accelerate rates
of hybridisation. The problem of increased background signal
in this scenario can be solved by the addition of an excess of
complementary quencher-labelled oligonucleotides after target
binding, to remove the signal from unhybridised probes
(Fig. 8C).124 This approach was applied to the detection
of 21 nt microRNAs (miRNAs) using locked nucleic acid
(LNA)/DNA mixmers.125 Another solution uses a pair of
Molecular Beacons to bind the same target strand
(Fig. 8D).126 This combination of intensity and co-localisation
oﬀers advantages over both separate methods; due to the
eﬃcient quenching in the ‘closed’ form, unbound probes
are unlikely to give rise to coincident signals even if two
(or more) unbound probes co-localise in the detection volume
by chance.
Another issue with the co-localisation approach when using
organic dyes as labels is that it is not possible to perfectly
overlap tightly focussed laser beams of diﬀerent colours in the
z-direction, due to their diﬀerent wavelengths. For example,
the confocal volumes of the blue argon-ion (488 nm) and red
HeNe (633 nm) lasers can only be overlapped to B30% of
the total volume, meaning that 70–80% of dual-labelled
complexes only encounter one of the two excitation
Fig. 7 (A) Detection of target DNA using enzymatic labelling with multiple ﬂuorophores. (B) Generating a signal upon hybridisation of a
bead-immobilised capture probe in the presence of a ﬂuorescent polymer. (C) Conformations of imidazolium-derivatised polythiophene when
bound to single-stranded (left) and double-stranded DNA (right).
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wavelengths and therefore are not detected as coincidence
events.27 To improve the detection eﬃciency, pairs of ﬂuor-
ophores that can be excited at a common wavelength, but
whose emission spectra are resolvable can be used, such as
quantum dots,127 or organic dye-doped energy transfer poly-
meric nanoparticles (TransFluoSpheres).128 These brighter
labels could also be detected by simpliﬁed wide-ﬁeld imaging
optical setups.129,130 Alternatively, a combination of quantum
dot and organic labels can be used as a reporter system.131 In
this example (Fig. 9), an Oregon Green-labelled probe is
ligated to a biotinylated probe in a template-dependent reac-
tion, followed by capture of the conjugate by multivalent
streptavidin-coated QD 605 quantum dots (lem = 605 nm).
Although fewer coincident complexes are formed because
multiple organic ﬂuorophores are captured by each quantum
dot, the resulting increased brightness of these species enables
a higher threshold to be used, which enhances the discrimina-
tion from background chance co-localisation events.
FRET-based detection
The use of SMD also allows the study of individual FRET
pairs (Fig. 3B). When a single donor is excited in suﬃcient
proximity to a suitable acceptor, photons are emitted by the
acceptor. If the FRET eﬃciency is less than 100%, emission
can be detected from both the donor and the acceptor
(Fig. 10A), and coincidence analysis can be applied.132 Indeed,
spFRET assays can be considered to be a subset of
co-localisation methods in which the donor and acceptor are
extremely close in space. In analytical assays for nucleic
acids, there are advantages over both intensity-based and
coincidence detection; the dependency of energy transfer on
the inverse of the sixth power of the interﬂuorophore separa-
tion means that it is not enough for two dyes to occupy the
detection volume simultaneously (diameter E 1 mm) to
generate a chance FRET signal, rather they must maintain a
proximity in the nanometre range for a signiﬁcant fraction of
the measurement time. The probability of this occurring by
chance is vanishingly small even at relatively high concentra-
tions. Furthermore, as only one excitation wavelength is used,
there is no loss of detection eﬃciency in confocal measure-
ments due to imperfect overlap of laser sources, although the
overlap of detection volumes deﬁned by separate pinholes
must still be optimised. However, direct excitation of the
acceptor at donor’s excitation wavelength and spectral cross-
talk from donor emission can lead to weak signals in the
Fig. 8 (A) Co-localisation based detection of nucleic acid sequences. In the absence of the target sequence, bursts in each channel are
uncorrelated. After probe binding, simultaneous bursts of ﬂuorescence are observed in both channels (*). (B) Generation of coincidence events by
binding of two labelled oligonucleotides to unlabelled target DNA. (C) Removal of the background from unbound probes by hybridisation to
complementary quencher strands after target binding. (D) Co-localisation of two ﬂuorescently-labelled Molecular Beacons on a target.
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acceptor emission channel. These possible sources of false
positives have to be ﬁltered out by thresholding.
An assay based on spFRET detection of a ‘reverse Mole-
cular Beacon’ formed by target-dependent ligation of a pair of
labelled oligonucleotides has been described by Wabuyele
et al.133 The two probes each contain a target-binding
sequence and a 10 nt arm sequence complementary to each
other. These arm sequences do not hybridise to form an
intermolecular duplex (due to its low thermodynamic
stability), but following ligation and re-equilibration a
conformational re-organisation into an intramolecular hairpin-
loop occurs, placing the donor (Cy5) in close proximity to the
acceptor (Cy5.5), leading to FRET (Fig. 10B). The detection
of a point mutation in the K-ras oncogene of 600 copies of
human genomic DNA (corresponding to a concentration of
50 aM) was demonstrated, using a single ligation cycle (5 min
duration) and spFRET measurement in electrokinetic ﬂow.
Since a high degree of spectral overlap between donor
emission and acceptor excitation is required for eﬃcient
FRET, the suppression of direct acceptor excitation requires
a donor ﬂuorophore with a large Stokes shift. Another
disadvantage of spFRET detection is that the total signal
from the acceptor will be lower than that obtained by excita-
tion at its absorption maximum if the energy transfer is less
than 100% eﬃcient, which could make binding events diﬃcult
to resolve from the background ﬂuorescence. The use of a
multivalent quantum dot as a donor for multiple organic
ﬂuorophores could address both of these issues, and take
advantage of the highly eﬃcient energy transfer reported
between quantum dots and organic dyes in ﬂow.134 The assay
developed by Zhang and co-workers (Fig. 10C)135 uses a
streptavidin-functionalised quantum dot (QD605) as a FRET
donor for Alexa Fluor 647. The excitation of the quantum dot
at 488 nm elicits negligible emission from Alexa Fluor 647
(lmax = 650 nm), and the capture of B50 acceptor duplexes
per quantum dot ensures high acceptor ﬂuorescence, enabling
a high threshold to be used. Detection in pressure-driven ﬂow
allowed a limit of detection of 4.8 fM unlabelled target DNA,
a tenfold improvement over a Molecular Beacon assay in a
head-to-head comparison. This concept has recently been
extended to capture two target sequences on single quantum
dots followed by detection using a combination of coincidence
and FRET.136 Others have used quantum dots with ﬂuores-
cent intercalators as FRET acceptors (Fig. 10D) such as
ethidium,137 BOBO-3,138 or YOYO-3,139 which could simplify
assay design.
Future challenges
This article has highlighted several assay formats that achieve
ultrasensitive ﬂuorescence-based detection of nucleic acids.
The progress in this burgeoning ﬁeld has been made possible
by contributions from many ﬁelds, including single molecule
spectroscopy, micro- and nanofabrication, chemistry of
organic and inorganic labels, and nucleic acid synthesis. An
important question remains though: what developments are
still required to translate these promising research methods
into real-world analytical applications? One important
challenge lies in the integration of devices for sample prepara-
tion (e.g. cell lysis, nucleic acid extraction and puriﬁcation),
hybridisation and detection. Most of the assays described here
rely on the use of pre-processed, puriﬁed DNA samples. Micro
total analysis systems (‘mTAS’), in which several steps are
carried out in one automated device, are one attractive
solution, particularly for ‘point-of-care’ applications. In this
setting, it is important that tests can be carried out by medical
personnel without the need for signiﬁcant additional training,
which is a major driver for the development of ‘sample-in-
answer-out’ instruments. mTAS are already becoming
established for detection of nucleic acids from biological
samples, but the vast majority use PCR ampliﬁcation.140 In
fact, very few platforms that integrate sample preparation with
single molecule detection have been reported so far. One
notable exception demonstrated lysis of mammalian cells,
speciﬁc antibody-labelling, analyte separation by electro-
phoresis, and ﬁnally SMFS in ﬂow for detection of proteins
from single cells, all in a single microﬂuidic chip.141 The
development of such multifunctional devices for nucleic acid
analysis will enable ultrasensitive tests to be practised outside
of specialist research laboratories.
Another way that the utility of ampliﬁcation-free genetic
analysis could be extended is in the simultaneous detection of
diﬀerent DNA sequences, or multiplexing. Applications for
this technology range from large scale expression analysis of
hundreds or thousands of human genes to monitoring
mutations in a few loci associated with cancer or detection
of a small panel of pathogen-speciﬁc genomic sequences.
Multiplexed analysis of ampliﬁed nucleic acids typically uses
positionally-encoded microarrays, or microparticle-based
assays, which may be encoded by many methods.142 Diﬀerent
Fig. 9 Generation of dual-labelled species by target-dependent
ligation of dye- and biotin-labelled probes followed by capture to a
quantum dot.
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strategies are required for coding single molecule assays; for
example Ho et al. demonstrated detection of three diﬀerent
sequences using target-directed co-localisation of pairs of
quantum dots with three diﬀerent emission wavelengths.129
Fig. 10 (A) Idealised data from FRET-based detection. In the absence of the target, there are no acceptor signals. Upon hybridisation, excitation
of the donor results in bursts of ﬂuorescence from the donor and acceptor simultaneously (*). (B) Reverse Molecular Beacon strategy for detection
by FRET. (C) Use of non-covalent capture to generate a FRET nanoassembly, with one quantum dot as a donor for multiple organic
ﬂuorophores. (D) Energy transfer between a quantum dot and ﬂuorescent intercalators upon hybridisation.
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This concept could be extended to higher order multiplexing
by the use of more spectroscopically resolvable quantum dots;
the use of ten resolvable emission colours as previously
demonstrated143 would generate 45 distinct coding pairs.
Others have used DNA nanostructures with multiple ﬂuores-
cent labels as barcodes. Dendrimer-like ‘Y-shaped’ and
‘X-shaped’ DNAs incorporating three- and four-way
junctions (Fig. 11A) have been used as nanobarcodes for
microsphere-based assays,143,144 though these could be
adapted for use in the single molecule detection mode. The
‘Nanostring’ nCounter system uses long, multiply ﬂuores-
cently-labelled sequences as coding and detection elements to
assay single mRNA molecules. The target is sandwiched
between the coded probe and a biotinylated capture sequence
by hybridisation. After immobilisation to a surface, the coding
sequence is stretched and aligned by an electric ﬁeld, which
enables counting and decoding of the resultant stripes of
ﬂuorescence by imaging (Fig. 11B). With seven coded ‘bits’
in one of four colours, an encoding capacity of 16 384 is
reached. This commercial system has allowed multiplexed
detection of 509 human genes with a sensitivity of 0.1–0.5 fM.145
Eﬀorts to build new barcodes for single molecule assays
should be greatly facilitated by the exciting recent develop-
ments in the assembly of nucleic acid nanostructures.146
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